RADIOPHARMACEUTICALS NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITIVE TREATMENT

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Discover comparable awards, related contractors, and agency purchasing history.

Same agency and NAICS · W81K0026FA128 — CLIN 2001AA AND CLIN 2001AB · Department of Defense · $5,369,485
Same agency and NAICS · W81K0026FA096 — COMPOUNDED PHARMACEUTICALS AT BAMC, JBSA FORT SAM HOUSTON, TX · Department of Defense · $356,929
Same agency and NAICS · W81K0026FA137 — DEFINITY ULTRASOUND CONTRAST AGENTS AT BROOKE ARMY MEDICAL CENTER, JBSA FORT SAM HOUSTON, TEXAS · Department of Defense · $80,762
Same NAICS · 75A50326C00007 — PROCUREMENT OF PHARMACEUTICALS - DOXYCYCLINE, SODIUM CHLORIDE, AND METHYLPREDNISOLONE · Department of Health and Human Services · $24,389,433
Same NAICS · 75A50326C00008 — BULK PHARMACEUTICAL REPLENISHMENT · Department of Health and Human Services · $18,625,476
Same NAICS · 15B51926F00000157 — 368-6052 VOSEVI 54 BOTTLES · Department of Justice · $1,017,949